Tata Medical and Diagnostics, the healthcare unit of India's Tata Group, launched its Covid-19 test kit which will be made available at laboratories and hospitals from December, its CEO Girish Krishnamurthy told Reuters.

The government-approved test, which can provide the final result within 90 minutes, will be manufactured at Tata's plant in Chennai in southern India which has the capacity to produce 1 million test kits a month, Krishnamurthy said.

The launch comes as India's Covid-19 cases rose by 45,903 to 8.55 million with deaths rising by 490 to 126,611, government data showed.

Opinion

Editorial

Missing in action
17 Mar, 2026

Missing in action

NOT exactly known for playing a proactive role in protecting the interests of Muslim nations and populations...
Risk to stability
Updated 17 Mar, 2026

Risk to stability

THE risks to Pakistan’s fragile economic recovery from the US-Israel war on Iran cannot be dismissed. Yet the...
Enrolment push
17 Mar, 2026

Enrolment push

THE federal government has embarked upon the welcome initiative to enrol 25,000 out-of-school children in Islamabad...
Holding the line
16 Mar, 2026

Holding the line

PAKISTAN’S long battle against polio has recently produced encouraging signs. Data from the national eradication...
Power self-reliance
Updated 16 Mar, 2026

Power self-reliance

PAKISTAN’S transition to domestic sources of electricity is a welcome development for a country that has long been...
Looking for safety
16 Mar, 2026

Looking for safety

AS the Middle East conflict enters its third week, the war’s most enduring victims are not those who wage it....